Catalent Finance Chief Leaves Company Amid Profit Warning
Wall Street Journal
The move came as contract drug manufacturer warned that productivity issues and higher costs would have a material impact on its results.
https://www.wsj.com/articles/catalent-finance-chief-leaves-company-amid-profit-warning-d8d7dc51